Clinical Trial Update: Non-inferiority, Open-label, Multicenter and Randomized Clinical Trial About the Treatment of Mild to Moderate Persistent Allergic Rhinitis [Phase 3]

View source ↗

Summary

A Phase 3 non-inferiority, open-label, multicenter randomized trial assessing treatment for mild to moderate persistent allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: Allergic Rhinitis | Phase 3 | Status: COMPLETED